Genpact Limited (NYSE:G) Shares Sold by Leeward Investments LLC MA

Leeward Investments LLC MA cut its stake in Genpact Limited (NYSE:G) by 2.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 286,468 shares of the business services provider’s stock after selling 8,334 shares during the period. Leeward Investments LLC MA owned approximately 0.16% of Genpact worth $12,304,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. JPMorgan Chase & Co. grew its stake in Genpact by 192.8% during the third quarter. JPMorgan Chase & Co. now owns 3,129,341 shares of the business services provider’s stock worth $122,701,000 after buying an additional 2,060,595 shares during the period. Tandem Investment Advisors Inc. grew its stake in Genpact by 390.5% during the fourth quarter. Tandem Investment Advisors Inc. now owns 2,129,915 shares of the business services provider’s stock worth $91,480,000 after buying an additional 1,695,706 shares during the period. Los Angeles Capital Management LLC purchased a new stake in Genpact during the third quarter worth approximately $19,779,000. Geode Capital Management LLC grew its stake in Genpact by 12.6% during the third quarter. Geode Capital Management LLC now owns 3,691,406 shares of the business services provider’s stock worth $148,142,000 after buying an additional 413,646 shares during the period. Finally, Empowered Funds LLC grew its stake in Genpact by 1,942.3% during the fourth quarter. Empowered Funds LLC now owns 325,379 shares of the business services provider’s stock worth $13,975,000 after buying an additional 309,447 shares during the period. 96.03% of the stock is owned by institutional investors and hedge funds.

Genpact Trading Down 2.3 %

NYSE G opened at $53.21 on Friday. Genpact Limited has a 12 month low of $30.23 and a 12 month high of $56.76. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.16 and a quick ratio of 1.85. The company has a market capitalization of $9.38 billion, a price-to-earnings ratio of 18.73, a price-to-earnings-growth ratio of 1.84 and a beta of 1.20. The company’s fifty day moving average price is $47.00 and its two-hundred day moving average price is $42.81.

Genpact (NYSE:G) last posted its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.82 EPS for the quarter, missing analysts’ consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. As a group, research analysts predict that Genpact Limited will post 3.21 earnings per share for the current fiscal year.

Genpact Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th will be paid a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 1.28%. This is an increase from Genpact’s previous quarterly dividend of $0.15. The ex-dividend date of this dividend is Tuesday, March 11th. Genpact’s dividend payout ratio is 21.48%.

Insiders Place Their Bets

In other Genpact news, CEO Balkrishan Kalra sold 9,000 shares of the stock in a transaction on Monday, November 25th. The shares were sold at an average price of $46.40, for a total transaction of $417,600.00. Following the sale, the chief executive officer now directly owns 267,404 shares of the company’s stock, valued at approximately $12,407,545.60. This represents a 3.26 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Piyush Mehta sold 12,000 shares of the stock in a transaction on Friday, January 10th. The stock was sold at an average price of $42.83, for a total transaction of $513,960.00. Following the sale, the senior vice president now directly owns 151,182 shares in the company, valued at $6,475,125.06. This trade represents a 7.35 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 34,600 shares of company stock valued at $1,538,120. Company insiders own 2.80% of the company’s stock.

Analysts Set New Price Targets

G has been the subject of several research reports. Robert W. Baird boosted their price objective on shares of Genpact from $44.00 to $48.00 and gave the stock a “neutral” rating in a research note on Friday, November 8th. TD Cowen upgraded shares of Genpact from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $45.00 to $60.00 in a research note on Friday, February 7th. Jefferies Financial Group upgraded shares of Genpact from a “hold” rating to a “buy” rating and upped their target price for the company from $44.00 to $55.00 in a research note on Tuesday, January 21st. Mizuho upped their target price on shares of Genpact from $45.00 to $55.00 and gave the company a “neutral” rating in a research note on Monday, February 10th. Finally, Needham & Company LLC upped their target price on shares of Genpact from $55.00 to $65.00 and gave the company a “buy” rating in a research note on Friday, February 7th. Six analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $48.44.

About Genpact

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.